American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 264-272 , August 2010

Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals

  • Gianni Bellomo, MD

      Affiliations

    • Department of Nephrology, San Giovanni Battista Hospital, Foligno(Pg), Italy
    • Corresponding Author InformationAddress correspondence to Gianni Bellomo, MD, Department of Nephrology, San Giovanni Battista Hospital, Via Arcamone,1, 06034 Foligno(Pg), Italy
    • ,
  • Sandro Venanzi, MD

      Affiliations

    • Department of Nephrology, San Giovanni Battista Hospital, Foligno(Pg), Italy
    • ,
  • Claudio Verdura, MD

      Affiliations

    • Department of Nephrology, San Giovanni Battista Hospital, Foligno(Pg), Italy
    • ,
  • Paolo Saronio, MD

      Affiliations

    • Department of Nephrology, San Giovanni Battista Hospital, Foligno(Pg), Italy
    • ,
  • Antonella Esposito, MD

      Affiliations

    • Transfusion Centre, San Giovanni Battista Hospital, Foligno(Pg), Italy
    • ,
  • Mario Timio, MD

      Affiliations

    • Department of Nephrology, San Giovanni Battista Hospital, Foligno(Pg), Italy

Received 18 September 2009 ,Accepted 21 January 2010.

References 

  1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–1821
  2. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992 (National Health and Nutrition Examination Survey). JAMA. 2000;283(18):2404–2410
  3. Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J. Hyperuricaemia and risk of cardiovascular disease and overall death (A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden). Acta Med Scand. 1988;224(6):549–555
  4. Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis. 1999;33(2):225–234
  5. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003;107(15):1991–1997
  6. Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 2002;89(8):12–17
  7. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998;29(3):635–639
  8. Johnson RJ, Feig DI, Herrera Acosta J, Kang DH. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension. 2005;45(3):18–20
  9. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13(12):2888–2897
  10. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38(5):1101–1106
  11. Sánchez-Lozada LG, Tapia E, Santamaría J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67(1):237–247
  12. Rosolowski ET, Ficociello LH, Maselli NJ, et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2008;3(3):706–713
  13. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension. 2006;47(5):962–967
  14. Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? (A prospective cohort study of Japanese male workers). J Epidemiol. 2000;10(6):403–409
  15. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001;24(6):691–697
  16. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44(5):642–650
  17. Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for developing decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16(3):791–799
  18. Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008;19(12):2407–2413
  19. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease. Arch Intern Med. 2009;169(4):342–350
  20. Feig D, Soletski E, Johnson RJ. Effect of allopurinol on the blood pressure of adolescents with newly diagnosed essential hypertension. JAMA. 2008;300(8):924–932
  21. Gores PF, Fryd DS, Sutherland DE, Najarian JS, Simmons RL. Hyperuricemia after renal transplantation. Am J Surg. 1988;156(5):397–400
  22. Fessel WJ. Renal outcomes of gout and hyperuricemia. Am J Med. 1979;67(1):74–82
  23. Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50(2):239–247
  24. Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009;53(5):796–803
  25. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S76–S110
  26. Levey AS, Stevens SA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612
  27. Bash LD, Astor BC, Coresh J. Risk of incident ESRD: comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010;55(1):31–41
  28. Lee J. Odds ratio or relative risk for cross-sectional data?. letter Int J Epidemiol. 1994;23(1):201–203
  29. Breslow NE. Covariance analysis of censored survival data. Biometrics. 1974;30(3):89–99
  30. Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res. 2008;31(3):433–441
  31. Eriksen B, Ingebretsen O. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69(2):375–382
  32. Lindeman R, Tobin J, Shock N. Longitudinal studies on the rate decline in renal function with age. J Am Geriatr Soc. 1985;33(4):278–285
  33. Lam C, Lim CK, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol. 2005;25(1):56–60
  34. Deckert T, Feldt Rasmussen B, Borch Johnsen K, Jensen T, Kofoed-Enevolsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 1989;32(4):219–226
  35. Beck L. Requiem for gouty nephropathy. Kidney Int. 1986;30(2):280–287
  36. Taniguchi A, Kamatani N. Control of renal uric acid excretion and gout. Curr Opin Rheumatol. 2008;20(2):192–197
  37. Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol. 2005;25(1):43–49
  38. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature. 2002;417(6887):447–452

 Originally published online as doi:10.1053/j.ajkd.2010.01.019 on April 12, 2010.

PII: S0272-6386(10)00491-9

doi: 10.1053/j.ajkd.2010.01.019

American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 264-272 , August 2010

Article Tools

* Image Usage & Resolution